Evidence map›Paper›PMID 26151934›Full record

ArticlePloS one2015

Functional Characterization of the Receiver Domain for Phosphorelay Control in Hybrid Sensor Kinases.

Emiko Kinoshita-Kikuta, Eiji Kinoshita, Yoko Eguchi, Shiho Yanagihara, Keisuke Edahiro, Yuki Inoue, Momoka Taniguchi, Myu Yoshida, Kaneyoshi Yamamoto, Hirotaka Takahashi and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Multitier regulation of theJournal of bacteriology · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. ArsRS-Dependent Regulation ofFrontiers in microbiology · 2018
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Emiko Kinoshita-KikutaDepartment of Functional Molecular Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Eiji KinoshitaDepartment of Functional Molecular Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Yoko EguchiDepartment of Science and Technology on Food Safety, Faculty of Biology-Oriented Science and Technology, Kinki University, Kinokawa, Japan.
Shiho YanagiharaDepartment of Functional Molecular Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Keisuke EdahiroDepartment of Functional Molecular Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Yuki InoueDepartment of Functional Molecular Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Momoka TaniguchiDepartment of Functional Molecular Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Myu YoshidaDepartment of Frontier Bioscience, Hosei University, Koganei, Japan.
Kaneyoshi YamamotoDepartment of Frontier Bioscience, Hosei University, Koganei, Japan.
Hirotaka TakahashiDivision of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama, Japan.
Tatsuya SawasakiDivision of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama, Japan.
Ryutaro UtsumiDepartment of Bioscience, Graduate School of Agriculture, Kinki University, Nara Japan.
Tohru KoikeDepartment of Functional Molecular Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Hiroshima University · JPHosei University · JPKindai University · JPCellFree Sciences (Japan) · JPEhime University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hybrid sensor kinase, which contains a histidine kinase (HK) domain, a receiver domain, and a histidine-containing phosphotransmitter (HPt) domain, conveys signals to its cognate response regulator by means of a His-Asp-His-Asp phosphorelay. We examined the multistep phosphorelay of a recombinant EvgAS system in Escherichia coli and performed in vitro quantitative analyses of phosphorylation by using Phos-tag SDS-PAGE. Replacement of Asp in the receiver domain of EvgS by Ala markedly promoted phosphorylation at His in the HK domain compared with that in wild-type EvgS. Similar Ala-substituted mutants of other hybrid sensor kinases BarA and ArcB showed similar characteristics. In the presence of sufficient ATP, autophosphorylation of the HK domain in the mutant progressed efficiently with nearly pseudo-first-order kinetics until the phosphorylation ratio reached a plateau value of more than 95% within 60 min, and the value was maintained until 180 min. However, both wild-type EvgS and the Ala-substituted mutant of His in the HPt domain showed a phosphorylation ratio of less than 25%, which gradually decreased after 10 min. These results showed that the phosphorylation level is regulated negatively by the receiver domain. Furthermore, our in vivo assays confirmed the existence of a similar hyperphosphorylation reaction in the HK domain of the EvgS mutant in which the Asp residue was replaced with Ala, confirming the validity of the control mechanism proposed from profiling of phosphorylation in vitro [corrected].

Indexed as

Signal TransductionAlanineAmino Acid SubstitutionAspartic AcidBinding SitesElectrophoresis, Polyacrylamide GelEscherichia coliEscherichia coli ProteinsHistidineHistidine KinaseMembrane ProteinsPhosphorylationPhosphotransferasesProtein KinasesAlaninearcB protein, E coliAspartic AcidbarA protein, E coliEscherichia coli ProteinsEvgS protein, E coliHistidineHistidine KinaseMembrane ProteinsPhosphotransferasesProtein Kinases

Identifiers

PMID26151934
PMCPMC4494823
OpenAlexW1502378764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.